Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Pediatric Cancer. Basic parameters: 1 Day — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, France +7
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
French African Pediatric Oncology Registry
Overview
The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population. Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.
Detailed description
This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome.
The register also collects information on vital status, treatment abandonment and loss to follow-up.
Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.
Primary outcome measures
- Number of children with a suspicion of any type of cancer in a given unit [Time frame: in any 12 month period]
- VITAL STATUS: [Time frame: in any 12 month period]
- Illness status [Time frame: in any 12 month period]
- Treatment Status [Time frame: in any 12 month period]
Eligibility criteria
Inclusion criteria
- Any child presenting at any one of the participating units for treatment
- Any child with any type of cancer
- Any child or adolescent less than 18 years of age.
Exclusion criteria
- No cancer found
- Age greater than 18 years -
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Burkina Faso · 2 centers
- Hopital Yalgado Ouedraogo — Ouagadougou
- Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle — Ouagadougou
Democratic Republic of the Congo · 2 centers
- Cliniques Universitaires de Kinshasa — Kinshasa
- Cliniques Universitaires de Lubumbashi (CUL) — Lubumbashi
Cameroon · 1 center
- Centre Mère et Enfant CME-FCB (Fondation Chantal Biya) — Yaoundé
Côte d’Ivoire · 1 center
- CHU de Treichville à ABIDJAN — Abidjan
France · 1 center
- GFAOP — Villejuif
Gabon · 1 center
- l'Institut de Cancérologie de Libreville — Libreville
Madagascar · 1 center
- HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona — Antananarivo
Mali · 1 center
- CHU Gabriel Touré (HGT) — Bamako
Mauritania · 1 center
- Centre National d'Oncologie (CNO) — Nouakchott
Niger · 1 center
- CNLC, Centre National de Lutte contre le Cancer — Niamey
Senegal · 1 center
- Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001 — Dakar
Togo · 1 center
- CHU Sylvanus Olympio — Lomé
Identifiers
NCT: NCT03803735 · GFAOP